Article
  • Controlled Release of Doxazosin in Multi-layered Pellet Using Polymer Blending
  • Youn JY, Park SW, Lee SY, Kim MS, Lee B, Khang G, Lee HB
  • 고분자 블렌딩을 이용하여 제조된 독사조신 다중층 펠렛의 약물방출제어
  • 윤주용, 박상욱, 이수영, 김문석, 이봉, 강길선, 이해방
Abstract
In this study, a multi-layered pellet was composed of a seed layer including a waterswellable agent and a drug layer containing doxazosin as a model drug, a porous membrane and a castor oil layer to control drug release. The pellet is prepared by a fluidized bed coating method. To confirm drug release from polymer blending in multi-layered pellet system, it is prepared by containing different ratio such as hydroxypropylmethylcellulose (HPMC):ethyl cellulose (EC) in drug layer and cellulose acetate (CA) : Eudragit RS in membrane. Also, to confirm the effect of oil in drug release, castor oil is coated. As a result, we observed regularly spherical pellet with diameter of 1500 μm. Release pattern of drug is confirmed by dissolution tester in aqueous media. The more the ratio of EC in drug layer, CA in membrane, and castor oil layer in pellet, the less the drug release is observed. Formation and the amount of pores in membrane is observed by SEM.

본 연구에서 제조한 다중층 펠렛은 수팽윤성 고분자를 포함하는 시드층, 모델 약물인 독사조신을 함유한 약물층, 약물의 방출을 제어하는 다공성막 그리고 지질층으로 구성되어 있으며, 유동층 코팅방법을 이용하여 제조하였다. 펠렛을 구성하는 각각의 층에 다양한 특성을 가지는 고분자들의 블렌딩에 따른 독사조신의 약물방출 거동을 확인하기 위하여 히드록시프로필메틸셀룰로오스(HPMC)와 에틸셀룰로오스(EC)의 양을 달리하여 약물층을 제조하였고, 셀룰로오스 아세테이트(CA)와 Eudragit® RS의 비율을 달리하여 다공성막을 제조하였다. 그리고 지질층에 의한 방출 거동을 확인하고자 피마자유의 두께를 다르게 하여 펠렛을 제조한 결과, 대략 1500 μm의 균일한 크기를 가지는 구형의 펠렛을 얻었다. 수용액에서 용출시험을 통하여 시간에 따른 약물방출량을 확인한 결과, 약물층에 첨가된 고분자 중, EC의 비율과 다공성막에서 CA의 비율이 증가하고, 피마자유층의 두께가 두꺼워지면 약물의 방출이 감소함을 알 수 있었다. 그리고 약물방출을 제어하는데 가장 큰 역할을 하는 다공성막의 다공형성거동 역시 SEM을 통해 확인하였다.

Keywords: fluidized-bed coater; doxazosin mesylate; castor oil; cellulose acetate; drug release

References
  • 1. Efentakis M, Politis S, Eur. Polym. J., 42, 1183 (2006)
  •  
  • 2. Efentakis M, Koligliati S, Vlachou M, Int. J. Pharm., 311, 147 (2006)
  •  
  • 3. Hamdani J, Moes AJ, Amighi K, Int. J. Pharm., 322, 96 (2006)
  •  
  • 4. Heng PWS, Chan LW, Tang ESK, Int. J. Pharm., 327, 26 (2006)
  •  
  • 5. Bechaard H, Nielsen GH, Ind. Pharm., 4, 53 (1978)
  •  
  • 6. Naelapaa K, Veski P, Pedersen JG, Anov D, Jorgensen P, Kristensen HG, Bertelsen P, Int. J. Pharm., 332, 90 (2007)
  •  
  • 7. Vaithiyalingam S, Khan MA, Int. J. Pharm., 234, 179 (2002)
  •  
  • 8. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R, J. Control. Release, 105, 226 (2005)
  •  
  • 9. Dyer AM, Khan KA, Aulton ME, Ind. Pharm., 21, 1841 (1995)
  •  
  • 10. Frohoff-Hulsmann MA, Schmitz A, Lippold BC, Int. J. Pharm., 177, 69 (1999)
  •  
  • 11. Schmidt C, Bodmeier R, Int. J. Pharm., 216, 9 (2001)
  •  
  • 12. Turton R, Cheng XX, Powder Technol., 150(2), 78 (2005)
  •  
  • 13. Glicksman LR, Hyre MR, Woloshyun K, Powder Technol., 77, 177 (1993)
  •  
  • 14. Watano S, Nakamura H, Hamada K, Wakamatsu Y, Tanabe Y, Dave RN, Pfeffer R, Powder Technol., 141(3), 172 (2004)
  •  
  • 15. Liu L, Khang G, Rhee JM, Lee HB, Bio-Med. Mater. Eng., 9, 297 (1999)
  •  
  • 16. Liu L, Khang G, Rhee JM, Lee HB, J. Control. Release, 67, 309 (2000)
  •  
  • 17. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB, J. Control. Release, 68, 145 (2000)
  •  
  • 18. Khang G, Ku J, Lee B, Lee HB, Biomater. Res., 4, 20 (2000)
  •  
  • 19. Youn JY, Ku J, Lee SY, Kim BS, Kim MS, Lee B, Khang G, Lee HB, Polym.(Korea), 31(4), 329 (2007)
  •  
  • 20. Jeong SC, Cho YH, Lee SY, Lee B, Kim MS, Khang G, Lee HB, J. Kor. Pharm. Sci., 36, 11 (2006)
  •  
  • 21. Jeong SC, Cho YH, Kim MS, Lee B, Khang G, Rhee JM, Lee HB, Polym.(Korea), 30(2), 112 (2006)
  •  
  • 22. Jeong SC, Chon SK, Jo YH, Kim MS, Lee B, Khang G, Lee HB, Polym.(Korea), 29(3), 288 (2005)
  •  
  • 23. Boza A, Carabello I, Alvarez-Fuents J, Rabasco AM, Ind. Pharm., 25, 229 (1999)
  •  
  • 24. Ammar HO, Khalil RM, Ind. Pharm., 23, 1043 (1997)
  •  
  • 25. Kristmundsdottir T, Gudmundsson OS, Ingvarsdottir K, Int. J. Pharm., 137, 159 (1996)
  •  
  • 26. Omari DM, Sallam A, Abd-Elbary A, El-Samaligy M, Int. J. Pharm., 274, 85 (2004)
  •  
  • 27. Goodhart FW, Harris MR, Murthy KS, Nesbitt RU, Pharm. Technol., 8, 64 (1984)
  •  
  • 28. Niopas I, Daftsios AC, J. Pharm. Biomed. Anal., 32, 1213 (2003)
  •  
  • 29. Colombo P, Bettimi R, Massimo G, Catellani PL, Santi P, Peppas NA, J. Pharm. Sci., 84, 991 (1995)
  •  
  • 30. Rowe RC, Int. J. Pharm., 29, 37 (1986)
  •  
  • 31. Harris MR, Ghebre-Sellassie I, Nesbitt RU, Pharm. Technol., 10, 102 (1986)
  •  
  • 32. Ho H, Chen CN, Sheu MT, J. Control. Release, 68, 433 (2000)
  •  
  • 33. Auda HSA, Najjar TA, Al-Khamis KI, Al-Hadiya BM, Ghilzai NM, Al-Fawzan NF, J. Pharm. Biomed. Anal., 22, 241 (2000)
  •  
  • 34. Meier MM, Kanis LA, Soldi V, Int. J. Pharm., 278, 99 (2004)
  •  
  • 35. Yanagawa F, Onuki Y, Morishita M, Takayama K, J. Control. Release, 110, 395 (2006)
  •  
  • 36. Yono M, Yamanoto Y, Yoshida M, Ueda S, Latifpour J, Life Sci., 81, 218 (2007)
  •  
  • 37. Ma N, Liu W, Li H, Chen B, Zhu Y, Liu X, Wang F, Xiang D, Zhang B, J. Pharm. Biomed. Anal., 43, 1049 (2007)
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 0379-153X(Print)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2022 Impact Factor : 0.4
  • Indexed in SCIE

This Article

  • 2008; 32(4): 322-327

    Published online Jul 25, 2008

  • Received on Nov 6, 2007
  • Accepted on Dec 3, 2007